Proactive Investors - Run By Investors For Investors

'We're pleased and on track with where we think we need to be' - Collagen Solutions' Jamal Rushdy

Jamal Rushdy, chief executive of Collagen Solutions (LON:COS) caught up with Proactive to run through the firm's preliminary results for the year to the end of March.

Rushdy puts their solid revenue growth down to a number of areas - ''We put up £4.1 mln in revenue and other income, that's about a 26% growth rate over the prior year''.

''We're seeing a number of areas, all in our core business, some of it's in our core collagen and development products but we've seen an uptick in tissue …so it's coming across a balanced set of our portfolio and geographies'', Rushdy adds.

''We're pleased … we're right on track with where we think we need to be''.

Meet ImmuPharma PLC, Synairgen plc, Tissue Regenix Group PLC, Tissue Regenix Group PLC and WideCells Group at our event, London, 02 November 2017. Register here »

Register here to be notified of future Collagen Solutions PLC articles
View full COS profile View Profile

Collagen Solutions PLC Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use